Gal Avraham Cohen
CIK: 0002015226
Transaction Breakdown
Open Market Buys (P)0
High conviction signal
Open Market Sales (S)0
Position reduction
Option Exercises (M)0
Derivative conversions
Awards (A)0
Compensation grants
Other (G, F, J, C, D, …)0
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BLRX
BioLineRx Ltd.
Director
Discretionary Trading P&L
Holdings
Transaction History (0 total)
1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024.
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| 1 Form 3 filing on record — initial statements of ownership, which report holdings, not trades. No Form 4 or Form 5 transactions since Sep 2024. | ||||||
0-0 of 0 transactions
Gal Avraham Cohen files insider reports with the SEC as Director of BioLineRx Ltd. (BLRX).
About Cohen Gal Avraham
Cohen Gal Avraham (SEC CIK 0002015226) files insider reports with the SEC as Director of BioLineRx Ltd. (BLRX).
Signal8 holds 1 ownership filing by Cohen Gal Avraham, a Form 3, filed on Mar 30, 2026. A Form 3 is an initial statement of ownership: it reports holdings, not trades, so no Form 4 or Form 5 transactions are on record since Sep 2024.
The business address on Cohen Gal Avraham's filings is in MODII'N.
Other insiders filing for BioLineRx Ltd. (BLRX)
- Yan Shaoyu, Director
- Schwartz Aharon, Director
- Serlin Philip A, Chief Executive Officer
- Zeevi Mali, Chief Financial Officer
- BORMANN-KENNEDY BARBARA-JEAN ANNE, Director